Baraitser-Winter cerebrofrontofacial syndrome (BWCFF) is a rare genetic condition caused by missense mutations in one of two genes that encode cytoplasmic actin, a protein essential for cell structure and movement. Since the genetic basis was pinpointed in 2012, research has steadily filled in the picture of how these mutations affect the brain, face, eyes, and hearing, and why the severity varies so much from person to person. The condition remains without a cure, but advances in genetic testing and a growing body of case reports are sharpening both the diagnostic path and the clinical outlook for affected families.
Two Genes, One Core Problem
BWCFF traces back to heterozygous missense mutations in either the ACTB gene, which encodes beta-actin, or the ACTG1 gene, which encodes gamma-actin. Both proteins belong to the cytoplasmic actin family and are expressed throughout the body, playing central roles in how cells maintain their shape, divide, and migrate during development. The mutations are almost always de novo, meaning they arise spontaneously in the affected person rather than being inherited from a parent. In the landmark 2012 study that identified the genetic cause, whole-exome sequencing of three families found de novo missense changes in ACTB and ACTG1, and subsequent sequencing of 15 additional affected individuals confirmed disease-causing mutations in every case, including two recurrent variants: ACTB p.Arg196His and ACTG1 p.Ser155Phe.1PubMed Central. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome
The fact that both genes encode structurally similar proteins helps explain why mutations in either one produce an overlapping set of features. But as researchers have catalogued more cases, it has become clear that the two genes are not interchangeable when it comes to clinical severity.
What the Mutations Do Inside Cells
Actin filaments are the structural scaffolding that gives cells their rigidity and allows them to crawl, divide, and respond to their environment. A 2025 study of the recurrent ACTB R196H variant found that patient-derived cells had roughly half the normal amount of filamentous actin, and their overall stiffness dropped about fourfold compared to healthy cells.2PubMed Central. The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability Cells carrying the mutation also proliferated and migrated more slowly, with the migration defect linked to lower levels of fibronectin, a protein involved in cell adhesion. The researchers noted that the actin filaments themselves looked structurally normal under high-resolution microscopy; the problem was that less actin was assembling into filaments in the first place.
This matters for understanding BWCFF because embryonic development depends heavily on cells moving to the right place at the right time. The brain, face, and eyes all form through precisely choreographed waves of cell migration. When those cells are softer and slower, the downstream effects can ripple across multiple organ systems, which is exactly the pattern clinicians see.
Facial and Skull Features
The syndrome was first described in 1988 on the basis of a distinctive facial appearance, and the face remains the feature most likely to prompt clinical suspicion. The hallmark findings include a prominent forehead ridge along the midline (metopic ridging), widely spaced eyes (hypertelorism), and drooping of the upper eyelids (bilateral ptosis).3PubMed. Update on the ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome In more pronounced cases the skull shape itself is affected, with trigonocephaly giving the forehead a triangular contour. These features are often recognizable in infancy, though they can be subtle enough in milder cases to go unnoticed until other developmental concerns surface.
Because the facial features exist on a spectrum, clinicians familiar with BWCFF have learned that no single finding is obligatory. Some patients have striking hypertelorism but minimal ptosis; others have the reverse. The phenotypic spectrum has broadened over time to include additional dysmorphic features, microcephaly, and deafness, reflecting the growing number of genetically confirmed cases.4European Journal of Medical Genetics. New ocular finding in Baraitser-Winter syndrome (BWS)
Brain and Neurological Involvement
The neurological picture in BWCFF ranges widely, from mild intellectual disability with largely normal brain imaging to severe cortical malformations visible on MRI. The most commonly reported brain findings are pachygyria (abnormally thick, smooth folds on the brain’s surface) and lissencephaly (a near-absence of normal brain folds), both of which reflect disrupted neuronal migration during fetal development.3PubMed. Update on the ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome These are the same types of cortical malformations seen in other migration disorders, and their severity correlates loosely with the degree of intellectual disability.
Some patients also show subcortical band heterotopia, periventricular heterotopia, and hippocampal malformations, all of which involve clusters of neurons that failed to reach their correct position during development.5PubMed. A case of Baraitser-Winter syndrome with unusual brain MRI findings: pachygyria, subcortical-band heterotopia, and periventricular heterotopia Seizures can accompany the more severe malformations, though not every person with abnormal brain imaging develops epilepsy. A brain MRI is now considered part of the standard workup whenever BWCFF is suspected, because the type and extent of cortical malformation helps guide expectations for cognitive development and the need for seizure monitoring.
Eye Findings
Ocular colobomata, gaps in the tissue of the eye caused by incomplete closure during embryonic development, were part of the original syndrome description and remain one of the most distinctive features. These gaps most often affect the iris, giving the pupil a keyhole shape at its lower margin, but can extend to the retina and optic nerve. In one detailed case report, a patient had iris colobomata at the inferior margin of both eyes along with large retinal colobomata visible on fundus examination. Her initial visual acuity was reduced, but with consistent follow-up it improved to near-normal over three years.6PubMed Central. Ocular findings in Baraitser-Winter syndrome with a de novo mutation in the ACTG1 gene: a case report
Beyond colobomata, ptosis itself can interfere with vision if the drooping eyelid blocks the pupil during the critical period of visual development in early childhood, potentially leading to amblyopia. Strabismus (misalignment of the eyes) and refractive errors such as hyperopic astigmatism have also been documented. Early and regular ophthalmologic evaluation is one of the more actionable parts of BWCFF management, because corrective lenses, patching for amblyopia, and surgical repair of ptosis can meaningfully improve visual outcomes.
Hearing Loss and Why the Gene Matters
Hearing impairment is common in BWCFF but far more likely with ACTG1 mutations than with ACTB mutations. A literature review found a significantly higher incidence of hearing loss among individuals carrying ACTG1 variants, with the hearing loss tending to appear early, anywhere from birth through the third decade of life, and to worsen over time.7PubMed Central. Hearing Loss in Baraitser–Winter Syndrome: Case Reports and Review of the Literature In the most severe cases, hearing aids or cochlear implants are eventually needed.
One particularly informative family illustrates how ACTG1 mutations can produce a spectrum even within a single kindred. A child was diagnosed with sensorineural hearing loss at age seven after failing a school hearing test. Her father had been diagnosed with moderate high-frequency hearing loss at age four and also had ptosis, strabismus, and reduced visual acuity. The child’s grandmother had worn bilateral hearing aids since childhood and had a speech deficit attributable to her hearing loss.8PubMed Central. A novel mutation in ACTG1 can cause either isolated hearing loss or Baraitser-Winter syndrome This family carried the same ACTG1 mutation across three generations, yet the grandmother’s presentation looked like isolated hearing loss while the father had features consistent with BWCFF. The case underscored that certain ACTG1 variants can produce anything from a single-organ problem to a multi-system syndrome, depending on factors that remain poorly understood.
ACTB Versus ACTG1 and Severity
Clinicians have noticed a pattern: individuals with ACTB mutations tend to be more severely affected than those with ACTG1 mutations. A study that systematically compared genotype-phenotype relationships concluded that ACTB mutations produce a distinctly more severe phenotype despite the structural similarity between beta-actin and gamma-actin and their overlapping expression patterns.9PubMed Central. Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations In practical terms, individuals with ACTB mutations are more likely to have pronounced cortical malformations, more significant intellectual disability, and a higher burden of structural anomalies in the heart and genitourinary system.
This genotype-severity relationship is not absolute. Some ACTB carriers have relatively mild presentations, and some ACTG1 carriers have substantial developmental challenges. But the trend is consistent enough that knowing which gene is involved can help families and clinicians calibrate expectations. An ACTG1 mutation identified at birth, for instance, makes severe lissencephaly somewhat less likely, though it does not rule out progressive hearing loss or meaningful cognitive impairment.
Why the two genes produce different severity is still an open question. Beta-actin and gamma-actin differ by only a handful of amino acids near the start of the protein, and both are expressed in virtually every cell type. One hypothesis is that beta-actin plays a more critical role during the early stages of cortical neuron migration, so disrupting it has a larger effect on brain development. But this has not been conclusively demonstrated.
Inheritance, Mosaicism, and Recurrence Risk
Because BWCFF mutations are overwhelmingly de novo, most affected individuals are the only person in their family with the condition. The recurrence risk for parents of an affected child is generally quoted as very low. However, germline mosaicism complicates that reassurance. In germline mosaicism, one parent carries the mutation in a fraction of their egg or sperm cells but not in other tissues, so standard blood-based genetic testing comes back normal. The first molecularly confirmed case of germline mosaicism in BWCFF was reported in a family with two affected siblings, both carrying the same mutation despite neither parent testing positive on routine sequencing.10PubMed. Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings
This finding is important for genetic counseling. While the risk of having a second affected child remains low in absolute terms, it is not zero even when both parents test negative for the mutation. Families who have had one affected child may be offered prenatal genetic testing in subsequent pregnancies. The existence of germline mosaicism also means that some apparently “de novo” cases in the literature may actually reflect low-level parental mosaicism that went undetected.
Reaching a Diagnosis
Historically, BWCFF was diagnosed on clinical grounds alone, based on the combination of facial features, eye findings, and brain malformations. That approach worked reasonably well for classic presentations but missed milder cases and could not distinguish BWCFF from other syndromes with overlapping features. The identification of ACTB and ACTG1 as the causative genes transformed the diagnostic process. Next-generation sequencing, whether through targeted gene panels or whole-exome sequencing, can now confirm the diagnosis definitively.
Prenatal diagnosis has also become feasible. In one reported case, fetal ultrasound findings prompted further investigation, and exome sequencing of fetal DNA revealed a de novo ACTB mutation, establishing the diagnosis of BWCFF before birth.11European Journal of Medical Genetics. Prenatal diagnosis of Baraitser – Winter syndrome using exome sequencing: Clinical report and review of literature Prenatal diagnosis allows families to prepare medically and emotionally, and to arrange delivery at a center with appropriate neonatal support.
The diagnostic journey for many families, though, is still long. BWCFF is rare enough that most pediatricians have never seen a case, and the facial features can overlap with other conditions involving hypertelorism and ptosis. Families often describe a period of uncertainty, with multiple specialist visits and sometimes years between the first sign of concern and molecular confirmation. Increasing awareness of the syndrome among geneticists and the growing availability of broad exome-sequencing panels are gradually shortening that timeline.
Living with BWCFF and Current Management
There is no treatment that addresses the underlying genetic defect. Management is entirely supportive, focused on identifying and treating the specific complications each individual has. Because the syndrome affects multiple organ systems, coordinated care across specialties is the norm rather than the exception. A child with BWCFF might see an ophthalmologist for coloboma and ptosis management, an audiologist for hearing monitoring, a neurologist for seizure surveillance, a cardiologist if a congenital heart defect is present, and a developmental pediatrician to guide educational and therapeutic interventions.
Speech and language therapy is particularly relevant given the frequency of hearing loss and intellectual disability. Physical and occupational therapy may address motor delays and joint contractures. Surgical interventions, when needed, are most commonly for ptosis repair to protect visual development, and less often for cardiac or genitourinary anomalies.
Life expectancy depends heavily on the severity of the associated malformations. Individuals with mild presentations and preserved cognitive function can live into adulthood with a good quality of life, as demonstrated by the multi-generational family described in the hearing-loss section. Those with severe cortical malformations, refractory seizures, or significant cardiac anomalies face a more guarded prognosis. Published case reports of adults with BWCFF remain scarce, which makes it difficult to give families a precise long-term outlook, but the trend in the literature is toward recognition that the syndrome encompasses a broad range of outcomes.
What Researchers Are Exploring Now
With the genetic cause established, research attention has shifted toward understanding the molecular consequences of specific mutations and whether any intervention could modify them. The 2025 finding that the R196H beta-actin variant halves filamentous actin content and dramatically reduces cell stiffness offers a potential therapeutic target: if a way could be found to stabilize actin polymerization in affected cells, some downstream effects might be mitigated.2PubMed Central. The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability That is speculative at this point, but it marks a shift from purely descriptive clinical work toward mechanism-focused investigation.
Genotype-phenotype studies continue to accumulate data, and each newly reported case adds granularity to the map of which mutations produce which outcomes. Larger registries of rare actin-related disorders are being developed, which should eventually allow more robust statistical analysis of prognosis by mutation type. For families navigating a fresh diagnosis, the practical takeaway is that genetic testing results are now worth discussing in detail with a clinical geneticist, because the specific mutation carries real prognostic information, even if it does not yet change treatment.
The Overlap with Isolated ACTG1 Hearing Loss
One of the more conceptually interesting developments in BWCFF research is the recognition that certain ACTG1 mutations can cause isolated hearing loss with no other syndromic features, while the same or closely related mutations in other individuals produce the full BWCFF picture. The three-generation family described earlier illustrates this directly: one family member had hearing loss and nothing else, while another had hearing loss plus ptosis, strabismus, and reduced vision.8PubMed Central. A novel mutation in ACTG1 can cause either isolated hearing loss or Baraitser-Winter syndrome This blurring of the boundary between a syndromic and a non-syndromic condition complicates genetic counseling and raises the question of what additional genetic or environmental modifiers are tipping the balance.
For audiologists and otolaryngologists, the clinical implication is that a child diagnosed with early-onset sensorineural hearing loss and an ACTG1 variant should be evaluated for the broader features of BWCFF, even if no other abnormalities are obvious at the time. And for families already managing an ACTG1-related hearing loss diagnosis, it is worth knowing that the same gene is implicated in a broader syndrome, not to cause alarm, but to ensure that a comprehensive exam has been done.